Binghamton University joins groundbreaking $42.8 million inflammatory disease treatment project

Binghamton University will play a key role in a federal grant of up to $42.8 million to develop an implantable device that acts as a living pharmacy to treat inflammatory diseases.

Opinion | Xylazine: New Drug, Same Old Mistakes

Marino is a medical toxicologist, addiction medicine specialist, and emergency physician. Reports of the drug xylazine being detected in overdoses across the U.S. have been

July 11, 2023

Sarissa and Alex Denner lose fight for board seats at Alkermes

Sarissa Capital Management’s three nominees to the Alkermes board failed to gain enough votes at a shareholder meeting, and all seven of the company’s board

June 30, 2023

Rectal Botox Injections Improved Fecal Incontinence, Urgency

Botulinum toxin type A (Botox) injections in the rectum reduced episodes of fecal incontinence and urgency, a randomized controlled trial showed. Among nearly 200 patients

December 23, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.